Search this site:
SORIN GROUP RECEIVES CONDITIONAL FDA APPROVAL TO CONDUCT IDE CLINICAL TRIAL FOR PERCEVAL™ S SUTURELESS AORTIC VALVE IN THE UNITED STATES
Primary objective of the prospective, non randomized trial is to demonstrate the safety and ...
SORIN GROUP ANNOUNCES RESULTS FOR THE FIRST QUARTER OF 2013
Consolidated results for the first quarter of 2013: Revenues were €178.7 million; ...
STOCKHOLDERS’ MEETING OF SORIN S.P.A. APPROVES 2011 FINANCIAL STATEMENTS AND APPOINTS NEW BOARD OF DIRECTORS
Milan, 30 April 2012– The Sorin S.p.A. stockholders’ meeting held today and ...
Cardiac Rhythm Management
Working at Sorin
Check for jobs